Kerri-Ann Millar
Director of Finance/CFO at CUE BIOPHARMA, INC.
Net worth: 23 327 $ as of 31/05/2024
Kerri-Ann Millar active positions
| Companies | Position | Start | End |
|---|---|---|---|
| CUE BIOPHARMA, INC. | Director of Finance/CFO | 30/04/2018 | - |
| Comptroller/Controller/Auditor | 01/09/2017 | 21/08/2020 | |
| Investor Relations Contact | 01/09/2017 | - |
Career history of Kerri-Ann Millar
Former positions of Kerri-Ann Millar
| Companies | Position | Start | End |
|---|---|---|---|
| FLEXION THERAPEUTICS, INC. | Comptroller/Controller/Auditor | 01/03/2014 | 01/09/2017 |
Training of Kerri-Ann Millar
| Boston University | Undergraduate Degree |
Statistics
International
| United States | 3 |
| Israel | 2 |
Operational
| Comptroller/Controller/Auditor | 2 |
| Director of Finance/CFO | 1 |
| Investor Relations Contact | 1 |
Sectoral
| Health Technology | 3 |
| Consumer Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 1 |
|---|---|
| CUE BIOPHARMA, INC. | Health Technology |
| Private companies | 1 |
|---|---|
Flexion Therapeutics, Inc.
 Flexion Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Flexion Therapeutics, Inc. operates as a biopharmaceutical company, which engages in the development and commercialization of novel and local therapies. It specializes in the treatment of patients with musculoskeletal conditions including osteoarthritis. It offers products under the Zilretta brand, an extended-release corticosteroid approved to manage osteoarthritis knee pain. The company was founded by Michael D. Clayman and Neil Bodick on November 5, 2007 and is headquartered in Burlington, MA. | Health Technology |
- Stock Market
- Insiders
- Kerri-Ann Millar
- Experience
